GSK acquisitions: every deal in 2026
The mergers, acquisitions and takeovers GSK has announced, agreed or completed in 2026, newest first, each with its value, status and sources.
3Deals tracked
$13.8bnDisclosed value
$10.6bnLargest deal
3Completed
GSK acquisitions: every deal in 2026
- 9 Jun 2026GSK agrees US$10.6bn deal for NuvalentGSK plc → Nuvalent, Inc.Healthcare / BiotechCompleted$10.6bn
- 25 Feb 2026GSK agrees US$950m deal for 35PharmaGSK plc → 35Pharma Inc.Healthcare / BiotechCompleted$950m
- 20 Jan 2026GSK agrees US$2.2bn deal for food allergy biotech RAPTGSK plc → RAPT Therapeutics, Inc.Healthcare / BiotechCompleted$2.2bn